Skip to site menu Skip to page content

Managing Human Challenge Trials

By SGS

Volunteer Infection Studies (VIS) or Controlled Human Infection Models (CHIM) are an extremely effective way to gather pre-clinical evidence on efficacy, minimize potential risks, and maximize the outcomes when progressing a new drug or vaccine onto critical clinical studies. Their success relies on careful preparation by an experienced team that is capable of adequately managing the risks associated with the study.

In this bulletin, we will share firsthand management experience from a recently completed malaria human challenge trial conducted by the SGS Clinical Pharmacology Unit in Belgium. We will focus on the main operational challenges encountered by the study team during the preparation and the strategies implemented to overcome them.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content